Glioma (Jan 2023)

How robust are the data in vorasidenib for isocitrate dehydrogenase-1 or isocitrate dehydrogenase-2 mutant low-grade glioma?

  • Eric T Wong

DOI
https://doi.org/10.4103/glioma.glioma_8_23
Journal volume & issue
Vol. 6, no. 3
pp. 29 – 30

Abstract

Read online

No abstracts available.